Revance Therapeutics, Inc. (RVNC)
NASDAQ: RVNC · IEX Real-Time Price · USD
3.950
+0.180 (4.77%)
At close: May 3, 2024, 4:00 PM
3.930
-0.020 (-0.51%)
After-hours: May 3, 2024, 7:23 PM EDT
Revance Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$14.00
Upside
+254.43%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +127.85% | Mar 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +203.80% | Feb 29, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $20 | Buy | Maintains | $42 → $20 | +406.33% | Feb 29, 2024 |
| Needham | Needham | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +355.70% | Feb 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $12 | Strong Buy | Maintains | $15 → $12 | +203.80% | Feb 23, 2024 |
| Barclays | Barclays | Buy Maintains $35 → $10 | Buy | Maintains | $35 → $10 | +153.16% | Jan 29, 2024 |
| Mizuho | Mizuho | Strong Buy → Hold Downgrades $16 → $9 | Strong Buy → Hold | Downgrades | $16 → $9 | +127.85% | Jan 29, 2024 |
| Needham | Needham | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +406.33% | Jan 9, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $30 → $8 | Strong Buy → Hold | Downgrades | $30 → $8 | +102.53% | Jan 9, 2024 |
| Mizuho | Mizuho | Strong Buy Maintains $35 → $16 | Strong Buy | Maintains | $35 → $16 | +305.06% | Nov 22, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $44 → $42 | Buy | Maintains | $44 → $42 | +963.29% | Nov 9, 2023 |
| Needham | Needham | Strong Buy Maintains $35 → $25 | Strong Buy | Maintains | $35 → $25 | +532.91% | Nov 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $41 → $15 | Strong Buy | Maintains | $41 → $15 | +279.75% | Nov 6, 2023 |
| Barclays | Barclays | Buy Maintains $40 → $35 | Buy | Maintains | $40 → $35 | +786.08% | Oct 23, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $25 → $12 | Hold | Maintains | $25 → $12 | +203.80% | Oct 11, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $38 → $33 | Strong Buy | Maintains | $38 → $33 | +735.44% | Sep 21, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $50 → $44 | Buy | Maintains | $50 → $44 | +1,013.92% | Sep 20, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $41 | Strong Buy | Reiterates | $41 | +937.97% | Sep 20, 2023 |
| Needham | Needham | Strong Buy Maintains $40 → $35 | Strong Buy | Maintains | $40 → $35 | +786.08% | Sep 20, 2023 |
| Exane BNP Paribas | Exane BNP Paribas | Sell → Hold Upgrades $20 | Sell → Hold | Upgrades | $20 | +406.33% | Aug 16, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $41 | Strong Buy | Reiterates | $41 | +937.97% | Aug 15, 2023 |